Overlap Syndromes: Exploring the Genetic Underpinnings

References

1. 6.
   1. Huizinga TW,
   2. Amos CI,
   3. van der Helm-van Mil AH,
   4. Chen W,
   5. van Gaalen FA,
   6. Jawaheer D,
   7. et al.

   Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA–DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 2005;52:3433–8.

   OpenUrlCrossRefPubMed
2. 7.
   1. El-Gabalawy HS,
   2. Goldbach-Mansky R,
   3. Smith D, II,
   4. Arayssi T,
   5. Bale S,
   6. Gulko P

   . Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum 1999;42:1696–705.

   OpenUrlCrossRefPubMed
3. 8.
   1. van der Helm-van Mil AHM,
   2. Verpoort KN,
   3. Breedveld FC,
   4. Huizinga TWJ,
   5. Toes REM,
   6. de Vries RRP

   . The HLA–DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006;54:1117–21.

   OpenUrlCrossRefPubMed
4. 9.
   1. Chan MT,
   2. Owen P,
   3. Dunphy J,
   4. Cox B,
   5. Carmichael C,
   6. Korendowych E

   . Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and mhc class ii Alleles in systemic lupus erythematosus. J Rheumatol 2008;35:77–83.

   OpenUrlAbstract/FREE Full Text
5. 10.
   1. Korendowych E,
   2. Owen P,
   3. Ravindran J,
   4. Carmichael C,
   5. McHugh N

   . The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology 2005;44:1056–60.

   OpenUrlAbstract/FREE Full Text
6. 11.
   1. Salliot C,
   2. Gottenberg J,
   3. Bengoufa D,
   4. Desmoulins F,
   5. Miceli-Richard C,
   6. Mariette X

   . Anticentromere antibodies identify patients with Sjögren’s syndrome and autoimmune overlap syndrome.J Rheumatol 2007;34:2253–8.

   OpenUrlAbstract/FREE Full Text